Proposed Rule Would Improve Medicare Advantage Prior Authorization and Transparency
January 30, 2025
This week, Medicare Rights submitted comments in response to the annual Medicare Advantage (MA) and Part D proposed rule for
📢 Action Needed: Tell Congress to Protect Federal Funding
Prescription Drugs
The Inflation Reduction Act (IRA) takes important steps to reduce drug prices and lower costs for people with Medicare and the program, such as capping beneficiary out-of-pocket spending; requiring Medicare to negotiate drug prices; and expanding eligibility for the full Part D low-income subsidy (LIS). We support an implementation process that centers the beneficiary experience and look forward to building upon these landmark policies.
Comments on Proposed 2026 Medicare Advantage Part D Policy Changes
January 27, 2025
A comprehensive commentary by the Medicare Rights Center on the Centers for Medicare & Medicaid Services (CMS) proposed rule for Contract Year 2026 (CMS–4208–P). The document outlines feedback and recommendations on changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and related policies. Topics include consumer protections, health equity, benefit transparency, drug affordability, and the integration of AI in healthcare services. This submission emphasizes safeguarding beneficiary access to affordable, equitable, and transparent healthcare.
Second Set of Part D Drugs for Medicare Negotiation Includes Blockbuster Diabetes and Weight-Loss Drugs
January 23, 2025
On January 17, the U.S. Department of Health and Human Services (HHS) announced the 15 Part D drugs that will
Millions of People With Medicare Drug Coverage to Save With New Cap in 2025
January 16, 2025
A new report from the Department of Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE) projects that
Medicare in 2025: Key Changes and Updates
January 9, 2025
Annual changes to premiums and cost-sharing, as well as the continued rollout of significant Part D reforms included in the
Some People Losing “Deemed” Status for the Low-Income Subsidy Remain Eligible for Assistance
November 21, 2024
What Is the Low-Income Subsidy (LIS)? The Low-Income Subsidy (LIS), also called Extra Help, is a federally administered assistance program
Millions See Cost Savings Under the Inflation Reduction Act
October 24, 2024
The Inflation Reduction Act (IRA) made significant improvements to Medicare prescription drug access and affordability, including by restructuring the Part
Comparing Plans is Especially Important This Open Enrollment Season Due to Changes in Part D Protections and New Options
October 17, 2024
Key components of the Inflation Reduction Act’s Part D reforms will be fully implemented for plans offered in 2025. These
Changes in Drug Coverage Coming in 2025 Could Influence Your Choice of Plan
October 10, 2024
Medicare open enrollment is just around the corner, and there will be major changes in 2025 that beneficiaries should keep in mind, and some of these changes may affect what plans people choose.
Medicare Rights Supports Building on the IRA’s Cost Protections for People With Medicare and Other Coverage
September 19, 2024
On Monday, Medicare Rights Center President Fred Riccardi participated in a press conference with Senator Kirsten Gillibrand. He spoke about the importance of key Inflation Reduction Act (IRA) cost protections for people with Medicare, in particular the law’s safeguards against unlimited enrollee expenses for covered Part D drugs.
Proposed Rule Would Improve Medicare Advantage Prior Authorization and Transparency
January 30, 2025
This week, Medicare Rights submitted comments in response to the annual Medicare Advantage (MA) and Part D proposed rule for
Comments on Proposed 2026 Medicare Advantage Part D Policy Changes
January 27, 2025
A comprehensive commentary by the Medicare Rights Center on the Centers for Medicare & Medicaid Services (CMS) proposed rule for Contract Year 2026 (CMS–4208–P). The document outlines feedback and recommendations on changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and related policies. Topics include consumer protections, health equity, benefit transparency, drug affordability, and the integration of AI in healthcare services. This submission emphasizes safeguarding beneficiary access to affordable, equitable, and transparent healthcare.
Second Set of Part D Drugs for Medicare Negotiation Includes Blockbuster Diabetes and Weight-Loss Drugs
January 23, 2025
On January 17, the U.S. Department of Health and Human Services (HHS) announced the 15 Part D drugs that will
Millions of People With Medicare Drug Coverage to Save With New Cap in 2025
January 16, 2025
A new report from the Department of Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE) projects that
Medicare in 2025: Key Changes and Updates
January 9, 2025
Annual changes to premiums and cost-sharing, as well as the continued rollout of significant Part D reforms included in the
Some People Losing “Deemed” Status for the Low-Income Subsidy Remain Eligible for Assistance
November 21, 2024
What Is the Low-Income Subsidy (LIS)? The Low-Income Subsidy (LIS), also called Extra Help, is a federally administered assistance program
Millions See Cost Savings Under the Inflation Reduction Act
October 24, 2024
The Inflation Reduction Act (IRA) made significant improvements to Medicare prescription drug access and affordability, including by restructuring the Part
Comparing Plans is Especially Important This Open Enrollment Season Due to Changes in Part D Protections and New Options
October 17, 2024
Key components of the Inflation Reduction Act’s Part D reforms will be fully implemented for plans offered in 2025. These
Changes in Drug Coverage Coming in 2025 Could Influence Your Choice of Plan
October 10, 2024
Medicare open enrollment is just around the corner, and there will be major changes in 2025 that beneficiaries should keep in mind, and some of these changes may affect what plans people choose.
Medicare Rights Supports Building on the IRA’s Cost Protections for People With Medicare and Other Coverage
September 19, 2024
On Monday, Medicare Rights Center President Fred Riccardi participated in a press conference with Senator Kirsten Gillibrand. He spoke about the importance of key Inflation Reduction Act (IRA) cost protections for people with Medicare, in particular the law’s safeguards against unlimited enrollee expenses for covered Part D drugs.